Gliomas

Gliomas, which comprise astrocytic, oligodendroglial, and ependymal lesions, are the most frequent primary intracranial tumors. This volume summarizes the enormous advances in our knowledge of gliomas that have occurred during recent years. The first part of the book focuses on the glial tumor entities, with detailed discussion of diagnosis, molecular genetics, and tumor origin. This section also contains a chapter on hereditary tumor syndromes associated with gliomas and the molecular mechanisms underlying these specific diseases. The second part is devoted to the clinical management of gliomas and provides insights into novel developments regarding neuroimaging, surgical management, radiation therapy, adjuvant therapy, experimental approaches, and the neurotoxicity of treatment. The final part of the book addresses angiogenesis and epigenetic regulation of gene expression in gliomas.

Produk Detail:

  • Author : Andreas Deimling
  • Publisher : Springer Science & Business Media
  • Pages : 259 pages
  • ISBN : 3540312064
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKGliomas

Diffuse Low-Grade Gliomas in Adults

Diffuse Low-Grade Gliomas in Adults
  • Author : Hugues Duffau
  • Publisher : Springer
  • Release : 21 June 2017
GET THIS BOOKDiffuse Low-Grade Gliomas in Adults

The second edition of this well-received volume has been revised and updated to reflect the advances in pathological classification and molecular epidemiology of diffuse low-grade gliomas (DLGG) in adults and offers an updated review on individualized therapies. This book presents the latest research pertaining to the diagnosis, genetics, therapy and management of DLGGs. It extensively covers recent research on the natural history of DLGGs and their interaction with the brain and reviews the new diagnostic and therapeutic strategies which increase

Gliomas

Gliomas
  • Author : Andreas Deimling
  • Publisher : Springer Science & Business Media
  • Release : 26 March 2009
GET THIS BOOKGliomas

Gliomas, which comprise astrocytic, oligodendroglial, and ependymal lesions, are the most frequent primary intracranial tumors. This volume summarizes the enormous advances in our knowledge of gliomas that have occurred during recent years. The first part of the book focuses on the glial tumor entities, with detailed discussion of diagnosis, molecular genetics, and tumor origin. This section also contains a chapter on hereditary tumor syndromes associated with gliomas and the molecular mechanisms underlying these specific diseases. The second part is devoted

Gliomas

Gliomas
  • Author : Anonim
  • Publisher : Academic Press
  • Release : 02 March 2016
GET THIS BOOKGliomas

Researchers’ knowledge of gliomas continues to advance rapidly at both the basic and translational levels, and Gliomas provides a thorough overview of the evolving fields of tumor biology and clinical medicine as they relate to our understanding of brain tumors. Gliomas reviews the current paradigms that underlie these fields, beginning with the molecular epidemiology of glioma susceptibility and prognosis through population-based science and genome-wide association studies. The book’s discussion of imaging modalities extends beyond advances in anatomical imaging to

Glioma

Glioma
  • Author : A.B.M.F. Karim,Edward R. Jr. Laws
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOKGlioma

Many recent developments in neuro-oncology relevant to clinical practice have contributed to improved patient care. The most im portant impact of these developments on treatment may have been a change in the attitudes of the neuro-oncologists involved in making decisions regarding patients with gliomas. From an era of uncertainty which led to therapeutic nihilism, we have entered one of active interventions based on objective parameters for the treat ment of gliomas, which may be either slow-growing or rapid kil lers.

Tumors of the Central Nervous System, Volume 2

Tumors of the Central Nervous System, Volume 2
  • Author : M.A. Hayat
  • Publisher : Springer Science & Business Media
  • Release : 03 April 2011
GET THIS BOOKTumors of the Central Nervous System, Volume 2

Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are

Gliomas

Gliomas
  • Author : J. Hekmatpanah
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOKGliomas

When I was asked by the Cancer Teaching Committee of the University of Chicago to set up a Symposium on Brain Tumors, I welcomed the opportunity to do so. But I felt that "Brain Tumors" was far too broad a subject to cover in a day and a half meeting. Furthermore, during the past decade, there have been a great many papers and symposiums on technical advancements in the treatment of benign brain tumors. On the other hand, while gliomas

New Techniques for Management of ‘Inoperable’ Gliomas

New Techniques for Management of ‘Inoperable’ Gliomas
  • Author : Michael E. Sughrue,Isaac Yang
  • Publisher : Academic Press
  • Release : 03 August 2019
GET THIS BOOKNew Techniques for Management of ‘Inoperable’ Gliomas

New Techniques for Management of 'Inoperable' Gliomas radically challenges the assumption that certain gliomas cannot be removed with modern techniques, contesting stereotypical thinking and establishing new paradigms in the field. Gliomas are primary brain tumors which are often fatal. Recent data has demonstrated that despite the fact that surgery cannot cure gliomas, patient survival is substantially improved by removing as much of the tumor as possible. This fact has raised the imperative that neurologists try to improve techniques to bring

High-Grade Gliomas

High-Grade Gliomas
  • Author : Gene H. Barnett
  • Publisher : Springer Science & Business Media
  • Release : 21 November 2007
GET THIS BOOKHigh-Grade Gliomas

This is truly an exciting time in the field of neuro-oncology, particularly in the area of hi- grade gliomas. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques and a myriad of clinical trials of medical therapies, the s- vival statistics for glioblastoma have not changed

The Glioma Book

The Glioma Book
  • Author : Michael E. Sughrue
  • Publisher : Thieme
  • Release : 25 October 2019
GET THIS BOOKThe Glioma Book

A unique resource on glioma leverages advances and firsthand insights to enact meaningful change Glioblastoma (GBM) or glioma is an extremely aggressive and malignant brain tumor, with cell infiltration, rapid invasion, and a high frequency of relapse. The Glioma Book by neurosurgeon Michael Sughrue is a highly personal book — a culmination of two years of writing and more than 1,000 surgeries. It presents a unique viewpoint with the potential to transform the traditional paradigm that too often informs treatment of this

Current Understanding and Treatment of Gliomas

Current Understanding and Treatment of Gliomas
  • Author : Jeffrey Raizer,Andrew Parsa
  • Publisher : Springer
  • Release : 02 December 2014
GET THIS BOOKCurrent Understanding and Treatment of Gliomas

This book reviews the significant advances in our understanding of glioma biology that have been achieved during the past decade and describes in detail the resultant new approaches to treatment. Improvements in surgical techniques, radiation therapy, and chemotherapy are comprehensively covered, with discussion of their impact in decreasing patient morbidity and increasing survival. In addition, individual chapters are devoted specifically to current treatment for low-grade gliomas, anaplastic gliomas, and glioblastoma multiforme. Other topics addressed include treatment of the elderly patient,

Tumors of the Central Nervous System, Volume 1

Tumors of the Central Nervous System, Volume 1
  • Author : M. A. Hayat
  • Publisher : Springer
  • Release : 23 April 2013
GET THIS BOOKTumors of the Central Nervous System, Volume 1

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant

Advances and Technical Standards in Neurosurgery, Vol. 35

Advances and Technical Standards in Neurosurgery, Vol. 35
  • Author : Anonim
  • Publisher : Springer Science & Business Media
  • Release : 13 February 2010
GET THIS BOOKAdvances and Technical Standards in Neurosurgery, Vol. 35

S. Price: Advances in imaging low grade gliomas - M. J. Riemenschneider, G. Riefenberger: Molecular neuropathology of low grade gliomas and its clinical impact - I . Whittle: What is the place of conservative management for adult supratentorial low grade glioma - D. Kurzwelly, U. Herrlinger, M. Simon: Seizures in patients with low grade gliomas -- incidence, pathogenesis, surgical management, and pharmacotherapy - L. Bello et al: Present day's standards in microsurgery of low grade gliomas - B. Baumert: Is there

Intracranial Gliomas Part I - Surgery

Intracranial Gliomas Part I - Surgery
  • Author : M.F. Chernov,Y. Muragaki,S. Kesari,I.E. McCutcheon
  • Publisher : Karger Medical and Scientific Publishers
  • Release : 14 December 2017
GET THIS BOOKIntracranial Gliomas Part I - Surgery

Aggressive surgical removal is generally considered the main initial management option for most intracranial gliomas. It often results in resolution or alleviation of neurological symptoms and signs, normalizes intracranial pressure, facilitates characterization of the neoplasm, creates optimal conditions for adjuvant therapy and neurorehabilitation, and leads to prolongation of progression-free and overall survival of patients. Leading experts in neurosurgical oncology have contributed to this volume, highlighting modern principles of surgery for both newly-diagnosed and recurrent intracranial gliomas in adult as well

Imaging Gliomas After Treatment

Imaging Gliomas After Treatment
  • Author : Tommaso Scarabino
  • Publisher : Springer
  • Release : 23 August 2016
GET THIS BOOKImaging Gliomas After Treatment

This atlas is a detailed guide to the imaging appearances of gliomas following treatment with neurosurgery, radiation therapy, and chemotherapy. Normal and pathological findings are displayed in detailed MR images that illustrate the potential modifications due to treatment. Particular emphasis is placed on characteristic appearances on the newer functional MR imaging techniques, including MR spectroscopy, diffusion-weighted imaging, and perfusion imaging. These techniques are revolutionizing neuroradiology by going beyond the demonstration of macroscopic alterations to the depiction of preceding metabolic changes

Malignant Gliomas: RMR V3 I2

Malignant Gliomas: RMR V3 I2
  • Author : Arnab Chakravarti, MD
  • Publisher : Demos Medical Publishing
  • Release : 09 October 2012
GET THIS BOOKMalignant Gliomas: RMR V3 I2

This issue of Radiation Medicine Rounds discusses the more salient topics surrounding the role of radiation therapy for malignant gliomas. the specialty of radiation therapy has increased in complexity over the years, yet as technology improves, the goal of improving outcomes while decreasing toxicity remains critical. Malignant gliomas remain among the most devastating of all malignancies, yet as conventional treatments (surgery, radiation, and chemotherapy) have become optimized overall survival has improved. the underlying molecular and genetic mechanisms of these tumors